Journey Medical Corp (DERM)

Every figure this model derived for DERM, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquireProductiveAssets 2024-12-31
cash 25,643,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 72,781,000 AssetsCurrent 2026-06-30
current liabilities 45,770,000 LiabilitiesCurrent 2026-06-30
equity 32,114,000 StockholdersEquity 2026-06-30
interest expense 3,893,000 InterestExpenseDebt 2026-06-30
ocf -7,492,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 68,181,000 Revenues 2026-06-30
sbc 6,055,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up DERM on one particular measure came for.

RatioValue
cash operating margin4.47
current ratio1.59
current ratio reported1.59
dilution pct19.92
fcf margin-10.99
growth cv2.42
interest cover-0.77
operating margin-4.41
owner earnings margin-19.87
revenue growth20.89
revenue growth per share0.81
roic-6.43
rule of 4016.48
sbc pct revenue8.88

What to be careful about

What this model itself distrusts about DERM's figures. Written by the derivation as it ran, not added afterwards.